In the realm of chemical intermediates, certain compounds stand out due to their critical role in producing high-value end products. Methyl (E)-3-(5-Nitrocyclohex-1-en-1-yl)acrylate, identified by its CAS number 900186-90-5, is one such compound, holding significant importance in the pharmaceutical manufacturing sector.

This chemical intermediate is primarily utilized in the synthesis of Vorapaxar Sulfate, a medication vital for managing cardiovascular health. The intricate process of creating Vorapaxar Sulfate necessitates a precursor with specific structural attributes and high purity, characteristics that Methyl (E)-3-(5-Nitrocyclohex-1-en-1-yl)acrylate possesses. Its structure, featuring a nitro group and an acrylate ester on a cyclohexene ring, provides the necessary functionality for the complex chemical reactions involved.

The demand for this compound highlights the need for reliable sourcing. Pharmaceutical companies often look for a dedicated methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate supplier China to ensure a stable supply of this essential pharmaceutical intermediate methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate. NINGBO INNO PHARMCHEM CO.,LTD. plays a key role in this supply chain, offering the CAS 900186-90-5 intermediate with guaranteed quality and consistency.

The high purity of this intermediate (≥98.0%) is crucial. It directly impacts the success of the subsequent synthetic steps and the overall quality of the final API. Pharmaceutical manufacturers understand that investing in high-quality intermediates like Methyl (E)-3-(5-Nitrocyclohex-1-en-1-yl)acrylate when they buy methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate is a fundamental aspect of ensuring therapeutic product integrity.

In conclusion, CAS 900186-90-5 is more than just a number; it represents a vital link in pharmaceutical production, enabling the creation of important treatments. Its reliable availability from manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. is key to the industry's ability to meet global health needs.